A Deep Dive into Second Generation Antipsychotic (SGA) Augmentation for Incomplete Response in Major Depression
There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”Be the second on Patreon:👉 https://www.patreon.com/PearlsandPrepThis podcast delves into the complexities of augmenting treatment for major depressive disorder (MDD) when standard selective serotonin reuptake inhibitors (SSRIs) yield an incomplete response. We explore the role of second-generation antipsychotics (SGAs) as adjuncts to enhance therapeutic efficacy. Specifically, we examine how these agents can target various serotonin receptors, thereby addressing specific symptoms such as…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.